Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Return on Sales (2016 - 2026)

Nutex Health (NUTX) has disclosed Return on Sales for 16 consecutive years, with 0.29% as the latest value for Q1 2026.

  • For Q1 2026, Return on Sales rose 5.0% year-over-year to 0.29%; the TTM value through Mar 2026 reached 0.22%, down 2.0%, while the annual FY2025 figure was 0.21%, 1.0% up from the prior year.
  • Return on Sales hit 0.29% in Q1 2026 for Nutex Health, up from 0.11% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.39% in Q4 2024 and bottomed at 14.89% in Q3 2022.
  • Average Return on Sales over 5 years is 0.85%, with a median of 0.01% recorded in 2024.
  • Year-over-year, Return on Sales tumbled -1489bps in 2022 and then soared 1482bps in 2023.
  • Nutex Health's Return on Sales stood at 0.2% in 2022, then plummeted by -100bps to 0.4% in 2023, then soared by 198bps to 0.39% in 2024, then plummeted by -72bps to 0.11% in 2025, then soared by 165bps to 0.29% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.29%, 0.11%, and 0.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.